Avraham Pharmaceuticals Overview

  • Founded
  • 2010
Founded
  • Status
  • Private
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $4M
Latest Deal Amount
  • Investors
  • 6

Avraham Pharmaceuticals General Information

Description

Developer of pharmaceutical products intended for the treatment and prevention of neurodegenerative disorders. The company's products are multifunctional compounds that combine neuroprotective mechanisms, reducing oxidative stress and microglial activation, inhibiting pro-inflammatory cytokines, enabling patients to get the cure of Alzheimer's disease and get diagnosed.

Contact Information

Website
avphar.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • 42 Hayarkon Street
  • Northern Industrial Zone
  • Yavneh 81227
  • Israel
+972 00-000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Avraham Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 25-Feb-2016 $4M 000.00 Completed Generating Revenue
4. Early Stage VC 17-Sep-2014 00.00 000.00 Completed Clinical Trials - Phase 2
3. Early Stage VC 21-Feb-2013 00.00 000.00 Completed Pre-Clinical Trials
2. Early Stage VC 14-Nov-2011 $3M $12M Completed Pre-Clinical Trials
1. Early Stage VC (Series A) 13-Jul-2010 $9M $9M Completed Pre-Clinical Trials
To view Avraham Pharmaceuticals’s complete valuation and funding history, request access »

Avraham Pharmaceuticals Executive Team (6)

Name Title Board Seat Contact Info
Marta Weinstock-Rosin Ph.D Scientific Co-Founder & Board Member
Michael Chorev Ph.D Scientific Co-Founder
Moussa Youdim Scientific Co-Founder
You’re viewing 3 of 6 executive team members. Get the full list »

Avraham Pharmaceuticals Board Members (5)

Name Representing Role Since
Marta Weinstock-Rosin Ph.D Avraham Pharmaceuticals Scientific Co-Founder & Board Member 000 0000
Ofer Gonen Self Board Member 000 0000
Tomer Kariv JD Pontifax Venture Capital Board Member 000 0000
Yaacov Michlin Self Chairman 000 0000
Yigal Koltin Self Board Member 000 0000
To view Avraham Pharmaceuticals’s complete board members history, request access »

Avraham Pharmaceuticals Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Integra Holdings Venture Capital Minority 000 0000 000000 0
Integra LifeSciences Corporation Minority 000 0000 000000 0
Technion Research and Development Foundation Venture Capital Minority 000 0000 000000 0
Clal Biotechnology Industries Venture Capital Minority 000 0000 000000 0
Pontifax Venture Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »